DIN/PIN Detail - 02322390

280000   CENTRAL NERVOUS SYSTEM AGENTS
281600   PSYCHOTHERAPEUTIC AGENTS
281608   ANTIPSYCHOTICS
28160804   ATYPICAL ANTIPSYCHOTICS

ABILIFY 10 MG ORAL TABLET

(ARIPIPRAZOLE)

Manufacturer:
OTSUKA PHARMACEUTICAL CO. LTD.
ECDET Review Status/Past Decision(s):

 2013/11/01 - No Change in Benefit Status


 2013/09/01 - Under Review


 2013/06/01 - Regular Benefit


 2013/03/01 - Under Review


 2013/02/01 - Under Review


 2011/02/01 - Not a Benefit

CDR Status/Past Decision(s):

 2015/04/01 - No Change in Benefit Status


 CDR - Do not list


 2012/01/01 - Regular Benefit


 2011/11/01 - Under Review


 CDR - List with criteria/condition


 2010/07/20 - Not a Benefit


 CDR - Do not list


To return to the printable Drug Benefit List and related publications, click here.

Last Updated: null

NOTICE:
The DBL, DBS and related publications require knowledgeable interpretation and are intended primarily for professional health care practitioners, pharmacies, hospitals and organizations associated with the manufacture, distribution and use of pharmaceutical preparations.

Electronic versions of all DBL and DBS related publications are unofficial versions and are provided for convenience and private use only. Official paper versions can be obtained from Alberta Blue Cross who publishes them on behalf of Alberta Health and Alberta Human Services.

Alberta Health reserves the right to make changes, without notice, to the List through the Interactive DBL(iDBL), and any such changes to the Interactive DBL(iDBL) are effective the date of the change (unless otherwise stated) and regardless of the date of publication in the paper version or updates.